Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1056/nejme2208554

Type

Journal article

Journal

The New England journal of medicine

Publication Date

09/2022

Volume

387

Pages

842 - 843

Addresses

From the Oxford University Clinical Research Unit, Ho Chi Minh City (G.T.), and the National Lung Hospital and the Vietnam National Tuberculosis Program, Hanoi (N.V.N.) - all in Vietnam; and the Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom (G.T.).

Keywords

Humans, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Treatment Outcome, Extensively Drug-Resistant Tuberculosis, Linezolid